Digital tool for monitoring patients off CML treatment
This study tests a digital tool to help doctors keep an eye on patients with chronic myeloid leukemia who have stopped their treatment. If you join, you'll use the tool to share health updates, which might help you stay safely off treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic myeloid leukemia (a type of blood cancer).
- You have been off your cancer treatment for up to 2 years.
- You have a device (like a smartphone or computer) with internet access.
- You are covered by the French social security system.
- You can read and understand French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study explores how digital tools (apps or websites) can help people affected by cancer, including patients, caregivers, and healthcare workers. If you are a current or past cancer patient, a caregiver, or an oncology professional, you may be able to join.
This trial is testing if a special electronic device can help you remember to take your oral medications for blood disorders. It's for people who need to take pills for at least 6 months and who have internet access.
This study tests whether older adults with acute leukemia can use a digital platform to report their symptoms and well-being during follow-up care. It aims to make monitoring easier and more responsive to patients' needs.
This study uses a smartphone or web app to track infections and quality of life in people with multiple myeloma or chronic lymphocytic leukemia who have a weakened immune system. The goal is to create a better screening tool for infections and understand how the disease and treatment affect daily life.
This study looks at how your 'biological age' (how old your body seems) affects how well you do on targeted therapy for chronic myeloid leukemia. It aims to personalize your care by combining age and frailty information.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
Hear when a new Chronic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.